Impetigo herpetiformis (IH) is a pregnancy-specific dermatosis that is currently considered a form of generalised pustular psoriasis and mainly occurs in late pregnancy during the third trimester. IH presents as erythematous patches and pustules and might have systemic involvement. The disease may be associated with severe maternal, fetal, and neonatal complications. IH treatment is very challenging, however, various therapeutic options are available and effective for disease treatment.
KroumpouzosG. Prurigo of pregnancy: an appropriate term for cases not associated with atopy. Obstet Med2021; 14: 197. doi: 10.1177/1753495X211029127.
2.
Saito-SasakiN, et al.Impetigo herpetiformis complicated with intrauterine growth restriction treated successfully with granulocyte and monocyte apheresis. Acta Derm Venereol2017; 97: 410–411. doi: 10.2340/00015555-2527.
3.
SugiuraK, et al.The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonistJ. Invest Dermatol. 2013; 133: 2514–2521. doi: 10.1038/jid.2013.230.
4.
SoutouBAractingiS. Skin disease in pregnancy. Best Pract Res Clin Obstet Gynaecol2015; 29: 732–740. doi: 10.1016/j.bpobgyn.2015.03.005.
5.
ImaiNWatanabeRFujiwaraH,et al.Successful treatment of impetigo herpetiformis with oral cyclosporine during pregnancy. Arch Dermatol2002; 138United States: 128–129. doi: 10.1001/archderm.138.1.128.
6.
ErbagciZErkiliçS. A case of recurrent impetigo herpetiformis with a positive family history. Int J Clin Pract2000; 54: 619–620.
7.
HensonTHTuliMBushoreD,et al.Recurrent pustular rash in a pregnant woman. Arch Dermatol2000; 136: 1055–1060. doi: 10.1001/archderm.136.8.1055-a.
SugiuraKNakasukaAKonoH,et al.Impetigo herpetiformis with IL36RN mutations in a Chinese patient: a founder haplotype of c.115 + 6T>C in east Asia. J Dermatol Sci2015; 79Netherlands: 319–320. doi: 10.1016/j.jdermsci.2015.06.003.
10.
NamaziNDadkhahfarS. Impetigo herpetiformis: review of pathogenesis, complication, and treatment. Dermatol Res Pract2018; 2018: 5801280. doi: 10.1155/2018/5801280.
11.
LakshmiCSrinivasCRPaulS,et al.Recurrent impetigo herpetiformis with diabetes and hypoalbuminemia successfully treated with cyclosporine, albumin, insulin and metformin. Indian J. Dermatol. 2010; 55: 181–184. doi: 10.4103/0019-5154.62757.
12.
GuerrieroC, et al.Impetigo herpetiformis occurring during N-butyl-scopolammonium bromide therapy in pregnancy: case report. J Biol Regul Homeost Agents2008; 22Italy: 141–144.
VaidyaDCKroumpouzosGBercovitchL. Recurrent postpartum impetigo herpetiformis presenting after a ‘skip’ pregnancy. Acta Derm Venereol2013; 93: 102–103. doi: 10.2340/00015555-1352.
15.
FoudaUMFoudaRMAmmarHM,et al.Impetigo herpetiformis during the puerperium triggered by secondary hypoparathyroidism: a case report. Cases J. 2009; 2: 9338. doi: 10.1186/1757-1626-2-9338.
16.
WolfRTartlerUStegeH,et al.Impetigo herpetiformis with hyperparathyroidism. J. Eur. Acad. Dermatology Venereol. 2005; 19: 743–746. doi: 10.1111/j.1468-3083.2005.01293.x.
17.
HuangYHChenYPLiangCC,et al.Impetigo herpetiformis with gestational hypertension: a case report and literature review. Dermatology2011; 222: 221–224. doi: 10.1159/000326913.
18.
OumeishOYFarrajSEBatainehAS. Some aspects of impetigo herpetiformis. Arch Dermatol1982; 118: 103–105.
19.
LimKSTangMBYNgPPL. Impetigo herpetiformis - A rare dermatosis of pregnancy associated with prenatal complications. Ann Acad Med Singapore2005; 34: 565–568.
20.
GaoQQXiMRYaoQ. Impetigo herpetiformis during pregnancy: a case report and literature review. Dermatology2013; 226: 35–40. doi: 10.1159/000346578.
21.
El FiboumiAChihebS. Impetigo herpetiformis: a rare dermotosis of pregnancy. Pan Afr. Med. J. 2018; 30: 8688. doi: 10.11604/pamj.2018.30.273.16424.
22.
HalevySKardaunSHDavidoviciB,et al.The spectrum of histopathological features in acute generalized exanthematous pustulosis: a study of 102 cases. Br J Dermatol2010; 163: 1245–1252. doi: 10.1111/j.1365-2133.2010.09967.x.
23.
CarmichaelSLShawGMMaC,et al.Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol2007; 197: 585.e1–7; discussion 683-4, e1-7, Dec. 2007, doi: 10.1016/j.ajog.2007.05.046.
24.
LehrhoffSPomeranzMK. Specific dermatoses of pregnancy and their treatment. Dermatol Ther2013; 26: 274–284. doi: 10.1111/dth.12078.
25.
PatsatsiA, et al.Cyclosporine in the management of impetigo herpetiformis: a case report and review of the literature. Case Rep Dermatol2013; 5: 99–104. doi: 10.1159/000350564.
26.
OzBBHackmanREinarsonT,et al.Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation2001; 71: 1051–1055. doi: 10.1097/00007890-200104270-00006.
27.
ChambersCDJohnsonDL. Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy. Birth Defects Res. A. Clin. Mol. Teratol. 2012; 94: 607–611. doi: 10.1002/bdra.23033.
28.
PuigLBarcoDAlomarA. Treatment of psoriasis with anti-TNF drugs during pregnancy: case report and review of the literature. Dermatology2010; 220: 71–76. doi: 10.1159/000262284.
29.
BozdagKOzturkSErmeteM. A case of recurrent impetigo herpetiformis treated with systemic corticosteroids and narrowband UVB. Cutan Ocul Toxicol2012; 31: 67–69. doi: 10.3109/15569527.2011.602035.
30.
SternRSLangeR. Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis. Arch Dermatol1991; 127: 347–350.
LuanLHanSZhangZ,et al.Personal treatment experience for severe generalized pustular psoriasis of pregnancy: two case reports. Dermatol Ther2014; 27: 174–177. doi: 10.1111/dth.12112.
33.
SárdyMPreiszKBereczM,et al.Methotrexate treatment of recurrent impetigo herpetiformis with hypoparathyroidism. Journal of the European Academy of Dermatology and Venereology : JEADV2006; 20England: 742–743. doi: 10.1111/j.1468-3083.2006.01473.x.
34.
BukhariIA. Impetigo herpetiformis in a primigravida: successful treatment with etretinate. J Drugs Dermatol2004; 3: 449–451.
